Jaguar Health, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $11.5M | $11.7M | $9.8M | $12.0M | $4.3M |
| Cost of revenue | $97,000 | $2.0M | $2.0M | $2.0M | $2.3M |
| Research and development | $25.0M | $16.5M | $18.6M | $17.6M | $15.1M |
| Operating income | -$45.9M | -$30.8M | -$34.3M | -$34.4M | -$40.7M |
| Interest expense | $67,000 | $231,000 | $6.4M | $12.7M | $8.4M |
| Pretax income | -$54.0M | -$39.3M | -$41.9M | -$48.4M | -$52.6M |
| Income tax expense | $0 | $0 | $0 | $0 | $0 |
| Net income | -$53.6M | -$38.5M | -$41,900 | -$48,400 | -$52,600 |
| Balance Sheet | |||||
| Cash and equivalents | $968,000 | $8.0M | $6.5M | $5.5M | $17.1M |
| Current assets | $20.3M | $32.2M | $28.0M | $22.3M | $28.4M |
| Total assets | $38.3M | $53.4M | $50.8M | $47.5M | $53.3M |
| Current liabilities | $40.7M | $19.7M | $14.0M | $30.3M | $15.5M |
| Total liabilities | $57.0M | $44.4M | $45.9M | $48.8M | $41.4M |
| Total debt | — | — | — | $6.2M | $6.2M |
| Stockholders' equity | -$18.7M | $6.5M | $4.9M | -$1.4M | $11.9M |
| Cash Flow Statement | |||||
| Cash from operations | -$23.7M | -$29.4M | -$33.2M | -$33.1M | -$35.0M |
| Depreciation and amortization | $1.9M | $1.9M | $2.0M | $2.0M | $1.7M |
| Stock-based compensation | $831,000 | $1.6M | $2.1M | $3.3M | $4.0M |
| Capital expenditure | $41,000 | $16,000 | — | $77,000 | $6,000 |
| Free cash flow | -$23.7M | -$29.4M | — | -$33.2M | -$35.0M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 603.1K
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.